New therapy helps immune cells detect, kill cancer in early tests

    Source: Xinhua| 2018-07-03 01:41:52|Editor: mmm
    Video PlayerClose

    WASHINGTON, July 2 (Xinhua) -- American researchers reported in a preclinical models that they can amplify macrophage immune responses against cancer using a self-assembling supramolecule.

    A study published on Monday in the journal Nature Biomedical Engineering showed that macrophages, immune cells that engulf and digest particles and pathogens, provided a first line of defense against bacteria and viruses and can also help destroy cancer cells.

    Macrophages play a paradoxical role, with M1s anti-tumorigenic, but inflammation-quelling M2s recruited by tumor cells to help them grow, according to the researchers.

    Also, tumors can send out "eat me not" signal that tricks M1 macrophages into letting them be, and in this way, pro-tumorigenic macrophages may make up 30 to 50 percent of a tumor's mass.

    Investigators have developed a therapeutic that delivers double attack to knock out these mechanisms.

    They re-programed the M2s into M1s by inhibiting the M2 signaling pathway, re-educating the macrophages and inhibiting the "don't eat me" protein.

    To address both the M2 "re-education" problem and to enhance the macrophages' capacity to eat tumor cells, the researchers used what they call a bi-functional or "one-two punch."

    They used a multi-component supramolecular system that self-organizes at the nanoscale to deliver an antibody inhibitor plus a drug inside the tumor.

    "This is the first time anyone has combined these two, a drug that targets M2 macrophages and an antibody that inhibits 'don't eat me signal,' in one delivery system," said Ashish Kulkarni at Department of Chemical Engineering of the University of Massachusetts Amherst.

    "We tested it in melanoma and breast cancer preclinical models, two aggressive cancers, and we plan to try it on different types of cancer and in combination with other current therapies like T-cell-based therapies now used in clinics," said Kulkarni.

    Mice that were untreated formed large tumors by Day 10, mice treated with currently available therapies showed decreased tumor growth, but mice treated with the new supramolecular therapy had complete inhibition of tumor growth, the reported.

    The team also reported an increase in survival and a significant reduction in metastatic nodes.

    The paper's co-author Shiladitya Sengupta at Brigham and Women's Hospital said, "We can actually see macrophages eating cancer cells," citing confocal microscopy images in the paper that show macrophages engulfing cancer cells.

    Kulkarni said next steps are to continue testing the new therapy in preclinical models to evaluate safety, efficacy and dosage.

    The supramolecular therapy they have designed has been licensed and they hope to move the therapeutic into clinical trials if preclinical testing continue to show promise.

    TOP STORIES
    EDITOR’S CHOICE
    MOST VIEWED
    EXPLORE XINHUANET
    010020070750000000000000011100001372968171
    主站蜘蛛池模板: CHINESE中国精品自拍| 亚洲丁香婷婷综合久久| 色综合色国产热无码一| 国产肥熟女视频一区二区三区| 中文字幕激情视频| 欧美videos欧美同志| 任你躁国产自任一区二区三区| 萝li交小说合集| 国产精品天干天干综合网| 一区二区三区免费电影| 日本护士xxxx视频| 亚洲国产精品无码久久98| 粉嫩小仙女扒开双腿自慰| 国产亚洲精品自在久久| 毛片基地看看成人免费| 女人扒开双腿让男人捅| 久久久亚洲欧洲日产国码农村 | 久久久久一级片| 欧美一区二区久久精品 | 91免费福利精品国产| 少妇BBW搡BBBB搡BBBB| 久久久国产99久久国产一| 欧美乱妇狂野欧美在线视频 | 1000部国产成人免费视频| 天天躁天天碰天天看| 中文字幕在线2021| 日韩国产成人资源精品视频| 亚洲日本一区二区三区在线| 皇后羞辱打开双腿调教h孕| 国产不卡视频在线播放| 国产chinesehd精品酒店| 国产肝交视频在线观看| videoshd泰国| 成人浮力影院免费看| 久久亚洲国产精品123区| 最近中文字幕mv手机免费高清| 亚洲欧洲美洲无码精品VA| 玉蒲团之偷情宝典| 制服丝袜中文字幕在线观看| 色窝窝无码一区二区三区成人网站| 国产成人精品无码片区在线观看 |